Mintezol Related Published Studies
Well-designed clinical trials related to Mintezol (Thiabendazole)
A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. [1995.12]
Comparative efficacy of levamisole, thiabendazole and fenbendazole against cattle gastrointestinal nematodes. [1995.05]
A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. [1994.05]
Theophylline and antiparasitic drug interactions. A case report and study of the influence of thiabendazole and mebendazole on theophylline pharmacokinetics in adults. [1990.01]
Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. [1989.10]
Well-designed clinical trials possibly related to Mintezol (Thiabendazole)
Topical treatment of tungiasis: a randomized, controlled trial. [2003.10]
Prevalence of anthelmintic resistance in gastrointestinal nematodes of dairy goats under extensive management conditions in southwestern France. [2001.12]
Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller. [2001.09]
Blinded, placebo-controlled trial of antiparasitic drugs for trichinosis myositis. [2000.07]
Failure of mebendazole in treatment of human hookworm infections in the southern region of Mali. [1997.07]
Chemotherapy of African AIDS diarrhoea: a preliminary study. [1993.01]
Randomized trial of albendazole versus tiabendazole plus flubendazole during an outbreak of human trichinellosis. [1988]
Other research related to Mintezol (Thiabendazole)
Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. [2011.07]
Assessment of potential immunotoxic effects caused by cypermethrin, fluoxetine, and thiabendazole using heat shock protein 70 and interleukin-1beta mRNA expression in the anuran Xenopus laevis. [2010.11]
Assessment of potential immunotoxic effects caused by cypermethrin, fluoxetine, and thiabendazole using heat shock protein 70 and interleukin-1beta mRNA expression in the anuran Xenopus laevis. [2010.07.24]
Factors affecting the synergy of thiabendazole, sodium bicarbonate, and heat to control postharvest green mold of citrus fruit. [2008.11.26]
Efficacy of thiabendazole, mebendazole, levamisole and ivermectin against gullet worm, Gongylonema pulchrum: in vitro and in vivo studies. [2008.01.25]
[Miticidal efficacy of thiabendazole against Otodectes cynotis (Hering, 1838) in dogs] [2006.10]
[Thiabendazole for the control of Strongyloides stercoralis infection in a hyperendemic area in Peru] [2005.10]
A novel genotoxic aspect of thiabendazole as a photomutagen in bacteria and cultured human cells. [2005.09.15]
Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. [2004.12]
Effect of thiabendazole on some rat hepatic xenobiotic metabolising enzymes. [2004.06]
Synthesis, X-ray crystal structure, antimicrobial activity and photodynamic effects of some thiabendazole complexes. [2004.02]
Effects of thiabendazole in Mansonella perstans filariasis. [2003.12]
Treatment of pediculosis capitis with thiabendazole: a pilot study. [2003.12]
Residue uptake and storage responses of Tarocco blood oranges after preharvest thiabendazole spray and postharvest heat treatment. [2002.04.10]
Thiabendazole uptake and storage performance of cactus pear [Opuntia ficus-indica (L.) Mill. Cv Gialla] fruit following postharvest treatments with reduced doses of fungicide at 52 degrees C. [2002.02.13]
Chronic toxicity of thiabendazole (TBZ) in CD-1 mice. [2001.12.28]
Treatment of widespread cutaneous larva migrans with thiabendazole. [2001.11]
Nematocidal activities of thiabendazole and ivermectin against the larvae of Strongyloides ratti and S. venezuelensis. [2001.08.31]
Thiabendazole induces urinary tract toxicity in male ICR mice. [2001.04.12]
Developmental toxicity of orally administered thiabendazole in ICR mice. [2001.04]
Localization and migration of benzimidazole resistant and susceptible adult Cooperia curticei in the small intestine of sheep after treatment with thiabendazole. [2000.11.01]
Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies. [2000.09]
[Cholestatic hepatitis ascribed to the use of thiabendazole] [1998.06.06]
[Hepatic transplantation for severe ductopenia related to ingestion of thiabendazole] [1997]
Comparative efficacies of closantel, ivermectin, oxfendazole, thiophanate and levamisole against thiabendazole resistant Haemonchus contortus in sheep. [1996.08]
Subchronic toxicity of thiabendazole (TBZ) in ICR mice. [1996.08]
Albendazole versus thiabendazole as therapy for trichinosis: a retrospective study. [1996.06]
Murine strongyloidiasis: the effects of cyclosporin A and thiabendazole administered singly and in combination. [1995.04]
Fasciola hepatica: mebendazole and thiabendazole pharmacokinetics in sheep. [1994.09]
An assessment of thiabendazole-resistant nematodes in some smallholder goat farms of Malaysia using the egg hatch assay method. [1993.12]
Critical tests of thiabendazole, oxibendazole, and oxfendazole for drug resistance of population-B equine small strongyles (1989 and 1990). [1993.06]
Studies on tissue cholinesterase in experimental trichinosis in albino rat. 2 effects of treatment with Mintezol and 5-fluorouracil-Endoxan. [1993.04]
Developmental toxicity of orally administered thiabendazole in Sprague-Dawley rats and New Zealand white rabbits. [1993.03]
Treatment of mixed Oesophagostomum and hookworm infection: effect of albendazole, pyrantel pamoate, levamisole and thiabendazole. [1993.01]
Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. [1993.01]
Sex difference in the nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine. [1992.03]
Nephrotoxicity of thiazoles structurally related to thiabendazole in mice depleted of glutathione by treatment with buthionine sulfoximine. [1992.01]
Prodrugs of thiabendazole with increased water-solubility. [1992]
Chronic oral toxicity and carcinogenicity study of thiabendazole in rats. [1991.11]
Identification of thiabendazole-resistant cyathostome species in Louisiana. [1991.08]
Resistance to thiabendazole, fenbendazole and levamisole in Haemonchus and Trichostrongylus species in sheep on a Kenyan farm. [1991.08]
Resistance of population-B equine strongyles to thiabendazole, oxfendazole, and phenothiazine (1981 to 1987). [1991.08]
[New trial with thiabendazole for treatment of human strongyloidiasis] [1991.03]
[Treatment of strongyloidiasis with mebendazole and its combination with thiabendazole] [1990.11]
[Levamisole, mebendazole, thiabendazole. Their effectiveness as helminthicides in African patients recently arrived in Cuba. From 1987 to 1988] [1990.05]
Effect of selection pressure for thiabendazole resistance on fitness of Haemonchus contortus in sheep. [1990.04]
Effect of thiabendazole and fenbendazole on glucose uptake and carbohydrate metabolism in Trichuris globulosa. [1990.03]
Micronodular cirrhosis after thiabendazole. [1989.06]
The effects of thiabendazole, mebendazole and cambendazole in normal and immunosuppressed dogs infected with a human strain of Strongyloides stercoralis. [1988]
An intervention study using thiabendazole suspension against Strongyloides fuelleborni-like infections in Papua New Guinea. [1987]
Other possibly related research studies
[Larva migrans "saxoniae": larva migrans infection in Saxony] [2004.01]
Field evaluation of the efficacy of fenbendazole in captive wild ruminants. [2005.11.05]
Cutaneous larva migrans: case report with current recommendations for treatment. [2005.05]
[Purpura in patient with disseminated strongiloidiasis] [2005.05]
An unusual case of ectopic tungiasis with pseudoepitheliomatous hyperplasia. [2004.12]
Pesticide patch test series for the assessment of allergic contact dermatitis among banana plantation workers in panama. [2004.09]
[Severe anguilluliasis in a chronic haemodialysis patient] [2005.01.29]
[Nosology and epidemiology of human toxocarosis--the recent situation in Austria] [2004]
An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species. [2004.11]
Pulmonary strongyloidiasis in a patient receiving prednisolone therapy. [2004.08]
Benzimidazole resistance in cyathostomin populations on horse farms in western Anatolia, Turkey. [2004.08]
[Cutaneous larva migrans: reports of pediatric cases and contamination by Ancylostoma spp larvae in public parks in Taciba, Sao Paulo State] [2004.03]
Toxocariasis of the central nervous system: with report of two cases. [2004.03]
Strongyloidiasis in patients at a comprehensive cancer center in the United States. [2004.04.01]
A survey of anthelmintic resistant nematode parasites in Scottish sheep flocks. [2003.11.03]
Cutaneous larva migrans. [2003.10]
Comparison of in vitro methods and faecal egg count reduction test for the detection of benzimidazole resistance in small strongyles of horses. [2003.05]
Strongyloides hyperinfection in a patient with sarcoidosis. [2003.03]
Severe drug rashes in three siblings simultaneously. [2003.05]
[Selective vs. mass treatment with antihelminthic drugs: experience in two hyperendemic communities] [2003.01]
[Toxocariasis: clinical and laboratory features in 54 patients] [2003.05]
Treatment of cutaneous larva migrans and Toxocara infection. [2003.04]
[A case of parasitism by Rhabditis sp in a child from Goiania, Goias, Brazil] [2002.09]
Massive infestation of cutanea larva migrans. [2002.10]
[A case of toxocariasis with eosinophil-rich pleural effusion] [2002.06]
[DNA damage in female workers exposed to pesticides in banana plantations at Limon, Costa Rica] [2002.06]
Analysis and partial reversal of multidrug resistance to anthelmintics due to P-glycoprotein in Haemonchus contortus eggs using Lens culinaris lectin. [2002.09]
Opinion on the diagnosis and treatment of human trichinellosis. [2002.08]
Induction of aneuploidy in male mouse germ cells detected by the sperm-FISH assay: a review of the present data base. [2002.07.25]
Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection. [2002.03]
Human strongyloidiasis in AIDS era: its zoonotic importance. [2002.03]
One confirmed and six suspected cases of cutaneous larva migrans caused by overseas infection with dog hookworm larvae. [2002.02]
Cutaneous larva migrans contracted in England: a reminder. [2001.07]
[Disseminated strongyloidiasis] [2001.04.28]
Reappearance of a remotely acquired infection. [1997.09]
Treatment of larva migrans cutanea (creeping eruption): a comparison between albendazole and traditional therapy. [2001.01]
Screening for Strongyloides infection among the institutionalized mentally disabled. [2001.01]
High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. [2000.10.12]
[A rare cause of asthma exacerbation: systemic anguilluliasis] [2000.02]
|
